top of page
HOME_Banners_1.3_RGB.jpg

WARPNINE is...

Western Australia's 
research into 
pancreatic,
gastro
intestinal 
and rar
e cancers.

WARPNINE Incorporated was established in May 2021 by Dr Andrew Dean, a  leading West Australian Oncologist, who recognised the escalating need for dedicated research, greater awareness, and increased support for people and families impacted by pancreatic, gastro-intestinal and rare cancers. 

BACKGROUND_2.jpg

More Australians die from pancreatic, gastro-intestinal and rare cancers each year than prostate and breast cancers combined. They have significantly worse prognosis and five-year survival rates.

​

Estimated numbers from 2021 show some of these heart-breaking statistics:

Number of people diagnosed  with pancreatic cancer:

4,261

Number of people diagnosed  with stomach or oesophageal cancer:

3,533

Number of people diagnosed  with  rare or less common cancer:

52,000

% of all cancer deaths as a result these 3 cancers combined:

62%

examining-sample-with-microscope.jpg

Forged from Philanthropy 

WARPNINE started with an idea: a vision to significantly improve survival from pancreatic, gastro-intestinal, and rare cancers.


Brought to fruition through the generosity of our founding donors, we strive to raise critical funds enabling translational research from laboratory to bedside, clinical research with immediate relevant clinical trials, that have direct patient benefit and projects that improve both the short and long-term health and wellbeing of Western Australians.

BACKGROUND.jpg

Key Actions to Achieve our Objectives 
We will:

Trials_Icon.png

Support revolutionary clinical trials that have direct patient benefit.

Awareness_Icon.png

Raise awareness of pancreatic, gastro-intestinal, and rare cancers, and advocate for change to improve the inequalities in funding and research for these malignancies in an effort to support earlier diagnosis and improve patient outcomes.

Research_Icon.png

Support research that has rapid, clinically meaningful benefit to patients. 

Leaders_Icon.png

Support future leaders to attract the best and brightest to the field of pancreatic,
gastro-intestinal, and rare cancer research.

Treatment_Icon.png

Contribute to the discovery and implementation of innovative and individualised treatments and therapies to treat and reduce cancer recurrence.

Care_Icon.png

Work to improve best practice in patient care to ensure the needs of patients and their families are met.

bottom of page